SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-033715
Filing Date
2020-07-28
Accepted
2020-07-28 10:01:26
Documents
71
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mcrb-10q_20200630.htm   iXBRL 10-Q 2708636
2 EX-10.1 mcrb-ex101_260.htm EX-10.1 227622
3 EX-10.2 mcrb-ex102_259.htm EX-10.2 71637
4 EX-31.1 mcrb-ex311_10.htm EX-31.1 10564
5 EX-31.2 mcrb-ex312_11.htm EX-31.2 10491
6 EX-32.1 mcrb-ex321_9.htm EX-32.1 7359
7 EX-32.2 mcrb-ex322_6.htm EX-32.2 7455
  Complete submission text file 0001564590-20-033715.txt   8308499

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA mcrb-20200630.xsd EX-101.SCH 50213
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mcrb-20200630_cal.xml EX-101.CAL 45689
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mcrb-20200630_def.xml EX-101.DEF 132672
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE mcrb-20200630_lab.xml EX-101.LAB 388412
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mcrb-20200630_pre.xml EX-101.PRE 278787
13 EXTRACTED XBRL INSTANCE DOCUMENT mcrb-10q_20200630_htm.xml XML 1335407
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37465 | Film No.: 201052220
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences